adverse drug reactions pharmacogenomics

Journal

Drug metabolism and disposition: the biological fate of chemicals
ISSN: 1521-009X
Titre abrégé: Drug Metab Dispos
Pays: United States
ID NLM: 9421550

Informations de publication

Date de publication:
04 Apr 2024
Historique:
accepted: 12 03 2024
received: 22 12 2023
revised: 15 02 2024
medline: 5 4 2024
pubmed: 5 4 2024
entrez: 4 4 2024
Statut: aheadofprint

Résumé

In the area of drug development and clinical pharmacotherapy, a profound understanding of the pharmacokinetics and potential adverse reactions associated with the drug under investigation is paramount. Essential to this endeavour is a comprehensive understanding about interindividual variations in ADME genetics and the predictive capabilities of

Identifiants

pubmed: 38575185
pii: dmd.123.001302
doi: 10.1124/dmd.123.001302
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Magnus Ingelman-Sundberg (M)

Department of Physiology and Pharmacology, Karolinska Institutet, Sweden magnus.ingelman-sundberg@ki.se.

Volker M Lauschke (VM)

Department of Physiology and Pharmacology, Karolinska Institutet, Sweden.

Classifications MeSH